Awarded contract

Supply of Optune Therapy for Home-Based Brain Tumour Treatment

Awarded
£3.6m
Published 27 Jul 2026

Provision of Optune Therapy devices and services for private patients receiving home-based brain tumour treatment through Imperial College Healthcare NHS Trust.

United Kingdom· LondonPublished 27 Jul 2026· 2 weeks agoFind a Tender

Decision brief

4 fields
  • Contract value
    £3,600,000
    Pounds sterling
  • Closing date
    Rolling
    No closing date published
  • Sector
    Browse related listings
  • Location
    United Kingdom
    London

Suppliers

1 supplier

Lifecycle

Awarded

Contract awarded. Originally published 2 weeks ago.

27 July 2026
Awarded — no open tender advertised

Brief

Imperial College Healthcare NHS Trust seeks qualified suppliers to provide Optune Therapy (Tumor Treating Fields) for private patients receiving brain tumour treatment at home. This opportunity involves the supply and potentially the management of Optune therapy devices and associated support services for eligible patients undergoing treatment within their domestic setting. Suppliers should have experience in delivering medical devices for cancer care, maintaining patient safety standards, and providing technical support for home-based therapies. Interested providers must demonstrate compliance with relevant healthcare regulations and quality assurance protocols.

Track record

1 award · 1 winner
Thin record

Only 1 prior award here — too little to read.

In healthcare medical, Imperial College Healthcare NHS Trust has awarded 1 contract to 1 supplier.

Who wins here
  1. Novocure1× · 100%

Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

More from Imperial College Healthcare NHS Trust

4 listingsView all →

Open in Healthcare & Medical

4 open listingsView all →